Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitamin C Yinqiao Tablets (维C银翘片) is a widely used pharmaceutical product in China for the treatment of the common cold and influenza. It is a hybrid formulation that combines Traditional Chinese Medicine (TCM) with Western chemical components. The TCM portion is derived from the 'Yin Qiao San' formula, which includes herbs such as Lonicera japonica and Forsythia suspensa, known for their anti-inflammatory and antiviral properties. The Western components typically include paracetamol (acetaminophen) for fever and pain relief, chlorpheniramine maleate to alleviate allergic symptoms like runny nose and sneezing, and ascorbic acid (Vitamin C) to support immune function. The product is manufactured by several companies, including Shaanxi Licai Group, and is approved for over-the-counter use to treat symptoms such as fever, headache, cough, and sore throat.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 维C银翘片.